Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1391-1400 of 9367

Page
per page
  1. Angiotensin I (human, mouse, rat)
    A1006 Angiotensin I (human, mouse, rat)
    Summary: Precursor of angiotensin II
      ≥129.6 mg/mL
  2. Endomorphin-1
    A1013 Endomorphin-1
    Summary: Agonist of μopioid receptors,highly potent and selective
      ≥14.9 mg/mL
  3. LEP (116-130) (mouse)
    A1024 LEP (116-130) (mouse)
    Summary: An antiobesity hormone
      insoluble in EtOH; ≥156 mg/mL
  4. SM-164
    A8815 SM-164
     22 Citation
    Target: Inhibitor of apoptosis proteins (IAP)
    Summary: Anticancer agent
      ≥56.07 mg/mL
  5. (S)-10-Hydroxycamptothecin
    B4745 (S)-10-Hydroxycamptothecin
    Target: Topoisomerases
    Summary: inhibitor of topoisomerase I
      ≥23.8 mg/mL
  6. Oxiracetam
    B4748 Oxiracetam
    Target: GABA receptors
    Summary: cyclic derivative of gamma-aminobutyric acid (GABA)
      insoluble in EtOH; ≥27.4 mg/mL
  7. GLPG0634 analogue
    B6116 GLPG0634 analogue
    Summary: JAK1 inhibitor, potent and selective
      insoluble in EtOH; insoluble in H2O; ≥31.67 mg/mL
  8. SC75741
    B4749 SC75741
    Summary: NF-κB inhibitor, potent
  9. CH5138303
    B4571 CH5138303
    Summary: Hsp90 inhibitor, orally available
      insoluble in H2O; insoluble in EtOH; ≥19.95 mg/mL
  10. HS-173
    B4492 HS-173
    Target: PI3K
    Summary: novel PI3K inhibitor
      ≥21.1 mg/mL

Items 1391-1400 of 9367

Page
per page